Le Lézard
Classified in: Health, Covid-19 virus
Subject: AVO

MEDICC Review: US Sanctions on Cuba Imperil Global Vaccine Equity


OAKLAND, Calif., Aug. 24, 2021 /PRNewswire-PRWeb/ -- With COVID-19 vaccination rates hovering at just over 1% in low-income countries and Cuban development of at least two efficacious vaccines, MEDICC Review editors argue that tightened US sanctions on Cuba also take aim at the world's poorest nations in Africa and elsewhere.

"Given the track record of Cuban biotechnology and the export potential for the new vaccines, it becomes clear that a US policy intended to hobble the Cuban government actually takes aim at the world's poorer countries, which could stand to benefit from Cuban science to address the dearth of life-saving vaccines for their populations," write MEDICC Review editors in the new issue, published today.

The editorial team, headed by Dr. C. William Keck and Gail Reed, notes that several governments in Latin America, Asia and Africa have expressed interest in the Cuban vaccines, two of which have completed clinical trials in Cuba: Abdala (reporting 92% efficacy) and Soberana 02 (91% efficacy), the first receiving emergency use authorization on July 9 by the country's regulatory authority. However, editors of the peer-reviewed journal cite Cuban vaccine developers who say that US sanctions have hindered and even blocked "purchase of dozens of equipment, supplies and ingredients for clinical trials and production?reagents, filtration tanks, potassium chloride solution, purification systems and more."

Such continued punishment, says the editorial, "is reprehensible. It is inhumane. It is also, in the context of COVID-19, lethal."

The editorial suggests that the Biden administration lift US sanctions on all pandemic-response items such as medicines and medical devices, a move it already made for Iran, Syria and Venezuela last June, but not for Cuba.

Otherwise, note the editors, "calls by President Biden for vaccine equity, human rights, regional stability and integration, and easing Cubans' suffering all ring hollow while his White House champions punishment during a pandemic...These sanctions-on-steroids aren't just bad public health policy, they are bad statesmanship."

The new MEDICC Review issue also carries an exclusive interview with the Director of the Cuban Regulatory Authority, CECMED, and content on COVID-19: pandemic response in Rwanda, South Africa and Zimbabwe; managing hypoxemia to prevent cytokine storms; and emergence of other zoonoses in times of COVID-19.

PLUS:
-More Accurately Estimating Iron-deficiency Anemia in Cuban Children
-Enhanced Recovery Protocols in Cardiac Surgery
-Improving Diagnosis of Ketosis-Prone Type 2 in Africa
-Novel Cuban Monoclonal Antibody Treatment for Non-Small Cell Lung Cancer

https://mediccreview.org

Media Contact

Jerrontay Foster, MEDICC, 6789048092, [email protected]

Twitter

 

SOURCE MEDICC


These press releases may also interest you

at 09:05
Skechers brings more strength to the pitch by adding West Ham United and Ghana National Team winger Mohammed Kudus to its roster of elite players competing in Skechers Football boots. Known to fans by his nickname Star Boy, Kudus had already been...

at 06:50
The "Nigeria Elevator and Escalator Market 2023-2029 Value, Size, Outlook, Industry, Analysis, Trends, Share, Revenue, Growth, Companies, COVID-19 Impact & Forecast: Market Forecast By Types, By Services, By End-User and Competitive Landscape" report...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:00
Growing intervention by governments and climate agencies across the globe to adopt clean and low carbon fuel for automotive and industrial applications has been a key driving factor for the growth of renewable energy market, a trend that is expected...

at 05:45
The global Specialty Food Ingredients Market, valued at $107.4 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $155.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.4% from...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...



News published on and distributed by: